Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flohr

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Leukemia|May 7, 2011
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatmentC Eckert, T Flohr, R Koehler, et al.
Der Radiologe|August 2, 2005
[On the way to isotopic spatial resolution: technical principles and applications of 16-slice CT]T Flohr, B Ohnesorge, K Stierstorfer, et al.
Leukemia|December 16, 2006
Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936A W Langerak, T J Molina, F L Lavender, et al.
Leukemia|October 24, 2003
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemiasS Hübner, G Cazzaniga, T Flohr, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia|March 14, 2008
Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemiaM Metzler, M S Staege, L Harder, et al.
Leukemia|February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingV H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Annals of Hematology|October 6, 1998
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy appliedT Fischer, A Neubauer, J Mohm, et al.
Leukemia|February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaT Flohr, A Schrauder, G Cazzaniga, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Leukemia|May 7, 2011
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatmentC Eckert, T Flohr, R Koehler, et al.
Der Radiologe|August 2, 2005
[On the way to isotopic spatial resolution: technical principles and applications of 16-slice CT]T Flohr, B Ohnesorge, K Stierstorfer, et al.
Leukemia|December 16, 2006
Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936A W Langerak, T J Molina, F L Lavender, et al.
Leukemia|October 24, 2003
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemiasS Hübner, G Cazzaniga, T Flohr, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia|March 14, 2008
Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemiaM Metzler, M S Staege, L Harder, et al.
Leukemia|February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingV H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Annals of Hematology|October 6, 1998
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy appliedT Fischer, A Neubauer, J Mohm, et al.
Leukemia|February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaT Flohr, A Schrauder, G Cazzaniga, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Pageof 8